Raymond James Financial Operating Cash Flow increased by 11090.0% to $1.10B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 839.3%, from $117.00M to $1.10B. Over 2 years (FY 2021 to FY 2025), Operating Cash Flow shows a downward trend with a -39.5% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.41B | $4.50B | -$2.29B | $1.12B | $5.74B | -$3.14B | -$624.00M | -$188.00M | $543.00M | $391.00M | $711.00M | $510.00M | $830.00M | $117.00M | $691.00M | $796.00M | -$10.00M | $1.10B |
| QoQ Change | — | +219.5% | -150.8% | +148.8% | +413.9% | -154.6% | +80.1% | +69.9% | +388.8% | -28.0% | +81.8% | -28.3% | +62.7% | -85.9% | +490.6% | +15.2% | -101.3% | >999% |
| YoY Change | — | — | — | — | +307.4% | -37.1% | -155.9% | -103.3% | +117.3% | +162.7% | +478.2% | — | +52.9% | -70.1% | -2.8% | +56.1% | -101.2% | +839.3% |